CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
An AI-generated site capture flags removed ductwork requiring rework on a commercial interior build-out, illustrating how OpenSpace and Disperse technology surfaces quality and progress issues from ...
NEW YORK--(BUSINESS WIRE)--Syntax Health, Inc., an enterprise SaaS-based solution for health plans and providers that accelerates alignment in value-based care (VBC), today announced the launch of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback